| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 05/18/2006 | WO2006052190A1 Indazole sulphonamide derivatives |
| 05/18/2006 | WO2006052189A1 Nitro indazole derivatives |
| 05/18/2006 | WO2006052026A1 Acid salt of benzimidazole derivative and crystal thereof |
| 05/18/2006 | WO2006051704A1 Imine compound |
| 05/18/2006 | WO2006051397A2 Oligonucleotide probes |
| 05/18/2006 | WO2006051341A1 Isotopically marked quinoline derivatives as adenosin a3 receptor ligands |
| 05/18/2006 | WO2006051312A1 Gastrin and cholecystokinin receptor ligands |
| 05/18/2006 | WO2006050992A1 Compounds having activity at nk3 receptor and uses thereof in medicine |
| 05/18/2006 | WO2006050991A1 Compounds having activity at nk3 receptor and uses thereof in medicine |
| 05/18/2006 | WO2006023931A3 Kinase inhibitors |
| 05/18/2006 | WO2006018184A3 Spirocyclic cyclohexane derivatives |
| 05/18/2006 | US20060106220 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 05/18/2006 | US20060106089 Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use |
| 05/18/2006 | US20060106079 Reacting methyl 2-methyl-3-(pyrazin-2-yl)-3-oxopropionate with phosphorus pentasulfide in presence of mixed solvent of toluene andxylene under reflux to produce an oltipraz crude crystal; recrystallization; sulfiding, cyclization |
| 05/18/2006 | US20060106067 Androgen receptor agonist; prostate cancer, hypogonadism; 4-[4-(hydroxymethyl)-1-piperidinyl]-1-naphthonitrile; 4-(4-hydroxy-2-methyl-1-pyrrolidinyl-1-benzothiophene-7-carbonitrile |
| 05/18/2006 | US20060106062 Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors |
| 05/18/2006 | US20060106061 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 05/18/2006 | US20060106047 [5-(1,4-Dioxa-8-aza-spiro[4.5]dec-8-yl)-4-pyridin-4-yl-thiophen-2-yl]-(3-methoxy-phenyl)-methanone; 1-[5-(3,5-Bis-trifluoromethyl-benzoyl)-3-pyridin-4-yl-thiophen-2-yl]-piperidin-4-one; secondary dysmenorrhea, amenorrhea, dysfunctional uterine bleeding, leiomyomata, endometriosis; carcinomas |
| 05/18/2006 | US20060106042 Substituted heterocyclpyrmidines |
| 05/18/2006 | US20060106041 Synthesis of indole analogs of 1-benzyl-3-(5'-hydroxymethy 1-2' -furyl) indazole (YC-1) as anti-platelet agents |
| 05/18/2006 | US20060106025 e.g. 2-Chloro-N-[4-(2-morpholin-4-yl-4-oxo-4H-chromen-8-yl)-dibenzothiophen-1-yl]-acetamide; anticancer, antitumor agents |
| 05/18/2006 | US20060105997 Mitotic kinesin inhibitors |
| 05/18/2006 | US20060105961 Method of using a cox-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia |
| 05/18/2006 | CA2588073A1 Isotopically marked quinoline derivatives as adenosin a3 receptor ligands |
| 05/18/2006 | CA2587667A1 Imine compound |
| 05/18/2006 | CA2586752A1 Substituted pyrrolidone compounds as ep4 agonists |
| 05/17/2006 | EP1657240A1 Pyridyltetrahydropyridines, pyridylpiperidines, and process for the production of both |
| 05/17/2006 | EP1657239A2 Chromene compound |
| 05/17/2006 | EP1657238A1 Fused pyrimidine derivative and use thereof |
| 05/17/2006 | EP1656355A2 Piperazine derivatives and methods of use |
| 05/17/2006 | EP1656353A1 Gabanergic modulators |
| 05/17/2006 | EP1656346A1 Novel substituted 3-sulfur indoles |
| 05/17/2006 | EP1656345A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 05/17/2006 | EP1656141A1 Treatment for alzheimer s disease and related conditions |
| 05/17/2006 | EP1656020A2 Pyridinylanilides |
| 05/17/2006 | EP1362047B1 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 05/17/2006 | EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317452B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317447B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1204652B1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 05/17/2006 | EP1140881B1 Antithrombotic amides |
| 05/17/2006 | EP1109787B1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
| 05/17/2006 | CN1774418A Substituted N-arylheterocycles, method for production and use thereof as medicaments |
| 05/17/2006 | CN1774245A Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| 05/17/2006 | CN1256334C Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derilatives as IP antagonists |
| 05/17/2006 | CN1256329C Herbicidal substituted benzoylpyrazoles |
| 05/17/2006 | CN1256326C 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency |
| 05/17/2006 | CN1256324C Pyrrolidine derivatives as factor Xa inhibitors |
| 05/16/2006 | US7045625 Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates |
| 05/16/2006 | US7045544 Myocardium; angina pectoris |
| 05/16/2006 | US7045517 Triazine compounds |
| 05/16/2006 | CA2244903C Hydroxamic acid derivatives for use with the treatment of diseases related to connective tissue degradation |
| 05/16/2006 | CA2192797C Indolinone compounds for the treatment of disease |
| 05/11/2006 | WO2006050120A2 Synthesis of cox-2 and faah inhibitors |
| 05/11/2006 | WO2006050035A1 Substituted 5-oxo pyrazoles and [1,2,4]triazoles as antiviral agents |
| 05/11/2006 | WO2006049952A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/11/2006 | WO2006049891A1 Trisubstituted thiophenes as progesterone receptor modulators |
| 05/11/2006 | WO2006048209A1 Novel bradykinin b1 antagonists, method for producing the same and the use thereof as drugs |
| 05/11/2006 | WO2006047888A1 2-substituted indoles, their precursors and novel processes for the preparation thereof |
| 05/11/2006 | WO2005103039A8 2- (3-aminopyrrolidin-1-yl) pyridines as melanin-concentrating hormone receptor an tagonists |
| 05/11/2006 | WO2005030209A8 Pyridine derivatives and use thereof as urotensin ii antagonists |
| 05/11/2006 | US20060100442 Reacting 2-{[(S)-2-methylpent-4-in-1-yl]oxy}-3,4,5,6-tetrahydro-2H-pyrane with acetaldehyde to produce 2RS,6S)-6-Methyl-7-[(RS)-(3,4,5,6-tetrahydro-2H-pyran-2-yl)oxy]hept-3-in-2-ol |
| 05/11/2006 | US20060100427 Alzheimer's disease and other diseases relating to amyloid deposits; neurodegenerative diseases |
| 05/11/2006 | US20060100261 Furan or thiopene derivative and medicinal use thereof |
| 05/11/2006 | US20060100259 Process for the preparation of substituted triazole compounds |
| 05/11/2006 | US20060100249 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 05/11/2006 | US20060100248 alleviating vision defects, multiple sclerosis, neurodegenerative diseases, stroke, spinal cord injury, Alzheimer's disease, Parkinson's disease or pain, comprising administering sodium channel modulators comprising pyrazole or indazole derivatives, such as 3-(5'-Hydroxymethyl-2'-furyl)-1-benzylindazole |
| 05/11/2006 | US20060100246 Synthesis of I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs, by reacting an aryl ketone, an aldehyde and a cyanoacetate with an ammonium salt |
| 05/11/2006 | US20060100237 Excitatory amino acid receptor antagonists |
| 05/11/2006 | US20060100224 Piperidine ouracil used as a medicament for treating bacterial infections |
| 05/11/2006 | US20060100193 Factor Xa inhibitors |
| 05/11/2006 | CA2589106A1 Pyridazine compounds, compositions and methods and their use in treating inflammatory diseases |
| 05/11/2006 | CA2586910A1 2-substituted indoles, their precursors and novel processes for the preparation thereof |
| 05/11/2006 | CA2585535A1 Novel bradykinin b1 antagonists, method for producing the same and the use thereof as drugs |
| 05/11/2006 | CA2585383A1 Substituted 5-oxo pyrazoles and [1,2,4]triazoles as antiviral agents |
| 05/11/2006 | CA2585337A1 Trisubstituted thiophenes as progesterone receptor modulators |
| 05/10/2006 | EP1655294A2 Chromene compound |
| 05/10/2006 | EP1655293A2 Chromene compound |
| 05/10/2006 | EP1654258A1 Sulfonyldihydro- benzimidazolone compounds as 5-hydroxytryptamine-6 ligands |
| 05/10/2006 | EP1654257A1 Aminopyrones and their use as atm inhibitors |
| 05/10/2006 | EP1654251A1 Chemical compounds |
| 05/10/2006 | EP1654247A1 Alkynyl aryl carboxamides |
| 05/10/2006 | EP1654244A1 3-aryl-4-hydroxyfuranone compounds and pharmaceutical and veterinary compositions containing them |
| 05/10/2006 | EP1654229A1 Piperidine derivatives as ccr5 receptor modulators |
| 05/10/2006 | EP1653967A2 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia |
| 05/10/2006 | EP1653961A1 Inhibitors of akt activity |
| 05/10/2006 | EP1653950A2 Nitrooxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-ii receptor blockers for the treatment of cardiovascular diseases |
| 05/10/2006 | EP1370553B1 Rho-kinase inhibitors |
| 05/10/2006 | EP1140786B9 Reductive alkylation of secondary amines with hydrosilane |
| 05/10/2006 | EP1104403B1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 05/10/2006 | EP1049700B9 Chemokine receptor antagonists and methods of use therefor |
| 05/10/2006 | CN1771247A Oxime derivatives and their use as pharmaceutically active agents. |
| 05/10/2006 | CN1771244A Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands |
| 05/10/2006 | CN1769274A Pyrazinone protease inhibitors |
| 05/10/2006 | CN1255396C Carboxylic acid derivatives having fused rings |
| 05/10/2006 | CN1255380C Pyrrolecarboxamides and pyrrolethioamides as fungicides |
| 05/09/2006 | US7041837 Heterocyclic compounds having hypolipidemic, hypocholesteremic activities process for their preparation and pharmaceutical compositions containing them and their use in medicine |